Break Up Big Medicine Act

Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: Not reported

Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: Not reported

Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Rep. Arrington, Jodey - Medicare coverage of cancer screenings H.R. 1407 - Permanent Telehealth from Home Act - Rep. Buchanan, Vern - Medicare telehealth coverage H.R. 1614 - To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program. - Rep. Kelly, Mike - Expand practitioners eligible for telehealth in Medicare H.R. 1627 - TREATS Act - Rep. Norcross, Donald - telehealth SUD treatment H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology. - Rep. Hern, Kevin - Removing in-person requirements for Medicare coverage for mental health telehealth H.R. 1899 - Audio-Only Telehealth Access Act - Rep. Feenstra, Randy - Medicare coverage for audio-only telehealth H.R. 2528 - Association Health Plans Act - Rep. Walberg, Tim - Association health plans treatment H.R. 3000 - Caring for Seniors Act - Rep. Fitzpatrick, Brian - Long-term care workforce programs and cost reduction H.R. 4206 - CONNECT for Health Act - Rep. Thompson, Mike - Telehealth expansion and oversight H.R. 5081 - Telehealth Modernization Act - Rep. Carter, Earl L. "Buddy" - Medicare telehealth flexibility extension H.R. 7537 - Corporate Crimes Against Health Care Act - Rep. Goodlander, Maggie - Private equity restrictions for health care industry H.R. 7790 - Medical Records Access Fairness Act - Rep. Foster, Bill - Requirements for providing protected health information to individuals H.R. 9504 - Tax Exempt Hospital Transparency Act - Rep. Murphy, Gregory - Hospital transparency requirements H.R. 9910 - Health Over Wealth Act - Rep. Jayapal, Pramila - For-profit health system requirements S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Sen. Crapo, Mike - Medicare coverage of cancer screenings S. 931 - COMPLETE Care Act - Sen. Cortez Masto, Catherine - Behavioral health integration S. 1056 - Home-Based Telemental Health Care Act - Sen. Rounds, Mike - mental health and SUD telehealth services S. 1261 - CONNECT for Health Act - Sen. Schatz, Brian - Telehealth expansion and oversight S. 1847 - Association Health Plans Act - Sen. Paul, Rand - Association health plans treatment S. 2709 - Telehealth Modernization Act - Sen. Scott, Tim - Medicare telehealth flexibility extension S. 3315 - Health Care Cybersecurity and Resiliency Act - Sen. Cassidy, Bill - Cybersecurity response and reporting requirements S. 3822 - Break Up Big Medicine Act - Sen. Warren, Elizabeth - Health care entity vertical integration restrictions S. 3829 - Corporate Crimes Against Health Care Act - Sen. Warren, Elizabeth - Private equity restrictions for health care industry S. 3834 - Expanded Telehealth Access Act - Sen. Daines, Steve - Medicare telehealth allowances Issues related to broadband and public health infrastructure; mental health and telehealth; behavioral health; behavioral health workforce expansion; rural health; post-partum care coverage; maternity care coverage; substance use disorder treatments; Health Savings Accounts; provider directories; artificial intelligence and privacy; cyber security issues; ACA Marketplace; ACA Marketplace Program Integrity; Mental Health Parity; Surprise Medical Billing; IDR; private equity ownership; transparency; prior authorization; IVF Coverage; ACA market regulations; maternal health coding; industry vertical integration; maternal health; vaccine coverage; and ICHRAs.

Client expense: $3,010,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office

Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act for Fiscal Year 2027 (NDAA - H.R.8800/S.4784) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to consumer pharmacy proposals CMS FY 2026 Medicare Part B Physician Fee Schedule Rule Break Up Big Medicine Act (S. 3822) Stop Corporate Take Over of Physicians Act (H.R.10444/S.5419) Role and value of community specialty physicians and Management Services Organizations (MSOs) NIH Restructuring/National Eye Institute Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)

Client expense: $405,804 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Affordability of Coverage, Site-Neutral Payments, Hospital Billing, Artificial Intelligence, Prior Authorization, Surprise Billing, Vertical Integration, Transparency, Anti-Steering/Tiering S.3822 - Break Up Big Medicine Act - A bill to prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes. H.R. 5582/S.2355 - Patients Deserve Price Tags Act - A bill to provide for hospital and insurer price transparency. H.R. 6248/S.4027 - Healthy Competition for Better Care Act - A bill to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. H.R.4710 - No Surprises Act Enforcement Act - A bill to increase penalties for group health plans and health insurance issuers for practices that violate balance billing requirements, and for other purposes. H.R. 9393, Lower Costs, More Transparency Act - A bill to require group health plans, individual market issuers, PBMs, hospitals, clinical laboratories, imaging service providers, and ambulatory surgical centers, to publicly disclose pricing and other specified information. H.R.9396 - Prior Authorization Accountability Act - A bill to require the displaying of claim denial rates. H.R.9397 - Premium Transparency Act - A bill to ensure health insurer accountability through publishing of overhead costs and claim payments, and to direct the Secretary of Health and Human Services to issue guidance on the provision of certain insurance information. H.R.9645 - Health Care Price Certainty for All Americans Act - A bill To promote health care price transparency, and for other purposes.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act S. 4509 Patients Before Monopolies Act H.R. 8779 Patients Before Monopolies Act S. 3822 Break Up Big Medicine Act H.R. 8800 National Defense Authorization Act S. 4784 National Defense Authorization Act S. 3097 Health Information Privacy Reform Act

Client expense: $480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HJRes 197 / SJRes 197, CRA related to the 2027 NBPP; HR 247 / S 46, Health Care Affordability Act; HR 6867 / S 3562, the NIH Clinical Trial Integrity Act; HR 3521 / S 4440, the Clinical Trial Modernization Act; HR 4710 / S 2420, No Surprises Act Enforcement Act; HR 5526 / S 1954, Biosimilar Red Tape Elimination Act; HR 5582 / S 2355, the Patients Deserve Price Tags Act; HR 6248 / S 4027, Healthy Competition for Better Care Act HR 6485 / S 43, Skinny Labels, Big Savings Act; HR 6867 / S 3562, NIH Clinical Trial Integrity Act; HR 7895, the PBM Kickback Prohibition Act; HR 8879 / S 4509, Patients Before Monopolies Act; HR 8908, the STOP GAMES Act; HR 9393, Lower Costs, More Transparency Act; HR 9396, the Prior Authorization Accountability Act; HR 9397, the Premium Transparency Act; HR 9645, the Health Care Price Certainty for All Americans Act; HR 9661 / S 1414, the Expedited Access to Biosimilars Act; HR 10370, the AIM to Cure Kids with Cancer Act; HR 10788, the Lower Premiums, Faster Payments Act; S 976, the Insurance Fraud Accountability Act; S 1041, Affordable Prescriptions for Patients Act; S 1095, Stop STALLING Act; S 1096, Preserve Access to Affordable Generics & Biosimilars Act S 1097, Interagency Patent Coordination & Improvements Act; S 2658, Medication Affordability & Patent Integrity Act; S 3014, Ensuring Timely Access to Generics Act; S 3822, the Break Up Big Medicine Act Policies to address the expiration of the enhanced Advanced Premium Tax Credits; Policies to improve transparency in hospital and insurer costs and finances; Policies to streamline pediatric patient access to subspecialist care via telemedicine; Policies to protect patients and consumers from junk insurance, including short-term limited duration insurance; Policies related to modernization of clinical trials; Policies related to the 2027 FDA user fee agreements; Implementation of the No Surprises Act; Policies related to oversight of insurance agents and brokers; Oversight and patient impact of the 340B program; Policies related to consolidation within the healthcare sector;

Client expense: $120,000 · Firm income: Not reported

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S.2276/ H.R. 3269; Eliminating Thickets to Improve Competition Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA)

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822 Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act - provisions related to interchangeability of biosimilars H.R.9393 Lower Costs, More Transparency Act of 2026

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 7148 (now Public Law 119-75) The Consolidated Appropriations Act provisions regulating pharmacy benefit manager practices S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools S. 3822 Break Up Big Medicine Act provisions related to insurer/PBM ownership or pharmacies S. 1954/HR 5526 The Biosimilar Red Tape Elimination Act - provisions related to interchangeability of biosimilars H.R.9393 Lower Costs, More Transparency Act of 2026

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 3014 - Ensuring Timely Access to Generics Act S.3822 - Break Up Big Medicine Act, all provisions S.526 - Pharmacy Benefit Manager Transparency Act of 2025, all provisions S.527 - Prescription Pricing for the People Act of 2025, all provisions Matters related to Drug Shortages Matters related to Competition and Transparency of Prescription Drugs Matters related to commonsense policy option to lower drug prices for patients Matters related to competition and transparency in the prescription supply chain Matters related to Pharmacy Benefit Managers

Client expense: $4,540,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to out of pocket costs. S. 3822 - Break Up Big Medicine Act - in support. HR 10373 - Protecting Workers Wages from Medical Debt Act - in support. S 5419 - Stop Corporate Takeovers of Physicians Act - in support. HR 10444 - Stop Corporate Takeovers of Physicians Act - in support. H.R.9948 - Addictive Design Act - in support.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to S.3822 - Break Up Big Medicine Act.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act

Client expense: $545,610 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Graduate Medical Education Certified Anesthesiologist Assistants Anesthesia workforce shortages HR 3890, Resident Physician Shortage Reduction Act of 2025: residency positions S.709, Conrad State 30 and Physician Access Reauthorization Act: Foreign physician immigration status S. 1380, Specialty Physicians Advancing Rural Care (SPARC) Act: physician shortages in rural areas HR 2028; Resident Education Deferred Interest Act (REDI Act): Student loan relief Anesthesia Research Funding Scope of Practice Merit-based Incentive Payment System, MIPS, MIPS Value Pathway Quality Payment Program, QPP Alternative Payment Model, APM QCDR - Qualified Clinical Data Registry Evaluation and Monitoring codes & cuts Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Brain health CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services Conditions of Participation - Anesthesia services, opt-outs, supervision CMS: Federal Independent Dispute Resolution (IDR) Process, Batching H.R.27, HALT Fentanyl Act: fentanyl scheduling and registration requirements H.R. 1227/S.475, Alternatives to PAIN Act of 2025: access to non-opioid pain management options Pain Medicine Prescription Drug Abuse CDC Opioid Prescribing Guideline H.R. 3595, Safe Prescribing Through Reporting Act of 2025: disclosure of certain records relating to substance use disorder medications to State prescription drug monitoring programs Drug shortages DEA Scheduling Propofol FDA Safe Use Initiative FDA Operating Room Fires FDA Opioids FDA Network of Experts FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) USP - US Pharmacopeia Compounding NIH Interagency Pain Research Coordinating Committee NIH: Funding, Indirect Costs, Indirect Grants, Overhead Agency for Healthcare Research and Quality (AHRQ) funding Long COVID research 21st Century Cures Initiative Out of Network/Out of Network Payment Network Adequacy Pre-authorization; prior authorization Insurance reform, shared savings, insurer accountability Affordable Care Act reform efforts Provider Nondiscrimination Change Healthcare, Change Healthcare data breach HR 292 Lorna Breen Reauthorization H.R. 3178, SAVE Healthcare Workers Act: To protect hospital personnel from violence, and for other purposes Maternal Mortality/Maternal Care Deserts Blood management 42 CFR Part 2, Confidentiality of Substance Use Disorder Patient Records: appropriate access to patient information essential for providing whole-person care S. 2759/H.R. 5283, the Healthcare Workforce Resilience Act, Exemption for Physicians from New H-1B Visa Policy and $100,000 Fee Medical journal fees No Surprises Act (NSA) - H.R.4710 / S. 2420, the No Surprises Enforcement Act H.R. 3164, the Ensuring Community Access to Pharmacist Services Act Advance Premium Tax Credits (APTCs) Federal regulation of commercial health insurance companies One Big Beautiful Bill (OBBB) Commercial payer/payment H.R.7961: H-1Bs for Physicians and the Healthcare Workforce Act S.3822: Breaking Up Big Medicine Act H.R. 4681: Specialty Physicians Advancing Rural Care (SPARC) Act Low-carbon anesthesia OMB Proposed Rule on federal funding / grants U.S. Departments of State and Homeland Security Visa delays Venezuelan patients Pain management in C-sections DEA Regulations Controlled Substances Act Amendments

Client expense: $270,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office

Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES

IPC supports S. 526 Pharmacy Benefit Manager Transparency Act of 2025 IPC supports S. 527 "Prescription Pricing for People Act of 2025 IPC supports H.R. 4317/S.3345 PBM Reform Act of 2025 IPC supports H.R. 3164/S. 2426 - "Main Street Pharmacy Access Act" IPC supports H.R. 6609 & H.R. 6610 - Pharmacists Fights Back Act IPC supports H.R. 5256 340B Affording Care for Communities and Ensuring a Strong Safety-Net Act (340B ACCESS Act) IPC monitors Trump Administration 340B Rebate Pilot Program adoption and implementation IPC supports OBBBA - Rural Health Transformation Program - grant implementation IPC monitors Senate BI-Partisan 340B working group - draft legislation IPC monitors Trump Administration overseas manufactured drug Section 232 tariffs investigation IPC monitors Trump Administration Drug Pricing Most Favored Nations status/Direct to Consumer (DTC) prescription drug distribution proposals IPC monitors HR 879/S.3794 Safe Drug Act of 2026 IPC is opposed to the HRSA 340B proposed rebate model IPC opposes HR 6509/S. 3794 Safe Drug Act of 2026. IPC opposes HR 5316 the "Drug Shortage Compounding Patient Access Act of 2025" IPC supports the Breakup Big Medicine Act S. 3822 IPC supports Protecting Pharmacies in Medicaid Act S. 927 IPC supports the US Department of Labor proposed rule on PBM transparency [RIN 1210-AB37]

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), SENATE, White House Office

Competition issues in the pharmaceutical benefit manager industry S. 3822 - Break Up Big Medicine Act Monetary penalties in PBM legislation

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

SUPPORT- Medicare for All (S. 1506 / H.R. 3069) Attended meeting on Break Up Big Medicine Act (S. 3822), introduced by Senator Warren and Hawley. Meetings were with Senator Ron Wyden Meeting with Congressional Progressive Caucus staff on Medicare for All Act (S. 1506 / H.R. 3069) Support S.1709/HR3415, Nursing Staffing Standards for Hospital Patient Safety and Quality Care Act Meeting with Senator Fetterman staff on Medicare for All Act (S. 1506 / H.R. 3069) "Meeting with Representative Alexandria Ocasio-Cortez staff to discuss Medicare for All Act (S. 1506 / H.R. 3069) " Coalition call with Senator Bernie Sander's team to discuss upcoming hearing on April 22 Secretary of HHS Robert F. Kennedy Jr on the FY27 Presidents HHS request Meeting with HELP Committee staff to discuss upcoming April 22 Committee hearing with Secretary of HHS Robert F. Kennedy Jr on the FY27 Presidents HHS request In response to hearing titled Lowering Health Care Costs for All Americans: Examining Policies to Increase Health Care Transparency, urged House Energy and Commerce Committee to markup H.R. 3069, Medicare for All Act. Support Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act SUPPORT- Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act (S. 1709 / H.R. 3415)

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: $15,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822

Client expense: Not reported · Firm income: $15,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

Issues related to S.3822 - Break Up Big Medicine Act.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Rep. Arrington, Jodey - Medicare coverage of cancer screenings H.R. 935 - Health Care Workforce Innovation Act - Rep. Garbarino, Andrew - Increase behavioral health workforce H.R. 1096 - HOPE and Mental Wellbeing Act - Rep. Salinas, Andrea - Medicare primary care visit requirements H.R. 1407 - Permanent Telehealth from Home Act - Rep. Buchanan, Vern - Medicare telehealth coverage H.R. 1523 - PREVENT DIABETES Act - Rep. DeGette, Diana - Virtual prevention programs in Medicare H.R. 1614 - To amend title XVIII of the Social Security Act to expand practitioners eligible to furnish telehealth services under the Medicare program. - Rep. Kelly, Mike - Expand practitioners eligible for telehealth in Medicare H.R. 1627 - TREATS Act - Rep. Norcross, Donald - telehealth SUD treatment H.R. 1867 - To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnished through telehealth and telecommunications technology. - Rep. Hern, Kevin - Removing in-person requirements for Medicare coverage for mental health telehealth H.R. 1899 - Audio-Only Telehealth Access Act - Rep. Feenstra, Randy - Medicare coverage for audio-only telehealth H.R. 2013 - Medicare Home Health Accessibility Act - Rep. Smucker, Lloyd - Medicare coverage of home-based occupational therapy H.R. 2049 - Access to Family Building Act - Rep. Gillen, Laura - access to reproductive technology H.R. 2404 - Remote Opioid Monitoring Act - Rep. Balderson, Troy - remote monitoring for opioid prescriptions H.R. 2528 - Association Health Plans Act - Rep. Walberg, Tim - Association health plans treatment H.R. 2741 - PEER Support Act - Rep. Salinas, Andrea - Behavioral health workforce shortage H.R. 3000 - Caring for Seniors Act - Rep. Fitzpatrick, Brian - Long-term care workforce programs and cost reduction H.R. 4206 - CONNECT for Health Act - Rep. Thompson, Mike - Telehealth expansion and oversight H.R. 4484 - ADAPT Act - Rep. Balderson, Troy - Behavioral health service reimbursement for supervised trainees H.R. 5081 - Telehealth Modernization Act - Rep. Carter, Earl L. Buddy - Medicare telehealth flexibility extension H.R. 5371 - Continuing Appropriations and Extensions Act, 2026 - Short term government funding bill; health care program funding H.R. 7064 - AI in Health Care Efficiency and Study Act - Rep. Hernandez, Pablo Jose - AI usage in health care H.R. 7537 - Corporate Crimes Against Health Care Act - Rep. Goodlander, Maggie - Private equity restrictions for health care industry H.R. 7787 - To amend title VII of the Public Health Service Act to strengthen the mental health workforce, and for other purposes. - Rep. Carter, Troy - Mental health professional workforce expansion H.R. 7790 - Medical Records Access Fairness Act - Rep. Foster, Bill - Requirements for providing protected health information to individuals H.R. 9504 - Tax Exempt Hospital Transparency Act - Rep. Murphy, Gregory - Hospital transparency requirements S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act - Sen. Crapo, Mike - Medicare coverage of cancer screenings S. 422 - Right to Contraception Act - Sen. Markey, Edward - Contraception and contraception services access S. 931 - COMPLETE Care Act - Sen. Cortez Masto, Catherine - Behavioral health integration S. 1056 - Home-Based Telemental Health Care Act - Sen. Rounds, Mike - mental health and SUD telehealth services S. 1227 - ABC Act - Sen. Markey, Edward - Family caregiver coverage paperwork S. 1261 - CONNECT for Health Act - Sen. Schatz, Brian - Telehealth expansion and oversight S. 1329 - PEER Support Act - Sen. Kaine, Tim - Behavioral health workforce shortage S. 1847 - Association Health Plans Act - Sen. Paul, Rand - Association health plans treatment S. 2356 - ADAPT Act - Sen. Barrasso, John - Behavioral health service reimbursement for supervised trainees S. 2709 - Telehealth Modernization Act - Sen. Scott, Tim - Medicare telehealth flexibility extension S. 3822 - Break Up Big Medicine Act - Sen. Warren, Elizabeth - Health care entity vertical integration restrictions S. 3829 - Corporate Crimes Against Health Care Act - Sen. Warren, Elizabeth - Private equity restrictions for health care industry S. 3834 - Expanded Telehealth Access Act - Sen. Daines, Steve - Medicare telehealth allowances Issues related to broadband and public health infrastructure; mental health and telehealth; behavioral health; rural health; substance use disorder treatments; Health Savings Accounts; provider directories; artificial intelligence and privacy; cyber security issues; ACA Marketplace; ACA Marketplace Program Integrity; Mental Health Parity; Surprise Medical Billing; IDR; private equity ownership; transparency; prior authorization; IVF Coverage; ACA market regulations; maternal health coding; maternal health; vaccine coverage; and ICHRAs.

Client expense: $3,010,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, White House Office

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,282,990 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA)

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,282,990 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care

Client expense: $530,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025 H.R. 6703, Lower Healthcare Premiums for All Americans Act H.R. 6610, The Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] S. 3822, Break Up Big Medicine Act S. 4509, The Patients Before Monopolies Act

Client expense: $3,570,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act S. 2658, Medication Affordability and Patent Integrity Act S. 3822, Break Up Big Medicine Act S. 4007, Family Grocery and Farmer Relief Act Potential legislation amending the Inflation Reduction Act (P.L. 117-169) Potential legislation seeking to impose pharmaceutical price controls to private sector payers Potential legislation related to digital piracy Potential legislation related to changes in Patent Trial and Appeal Board Proceedings Potential legislation related to implementing most favored nation style reference pricing Potential legislation related to detection of counterfeit imports Potential legislation related to protecting consumers from counterfeit goods online Various issues relating to patent examination practices and patent quality; patent filing fees and potential patent valuation fees; IP issues related to counterfeiting; pharmaceutical price controls; IP issues related to prescription drug pricing and labeling; implementation of the Inflation Reduction Act of 2022, Drug Price Negotiation Program (P.L. 117-169, subtitle B); ongoing practice of discretionary denials at the Patent Trial and Appeal Board

Client expense: $16,950,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Natl Institute of Standards & Technology (NIST), Natl Telecommunications & Information Administration (NTIA), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Copyright Office, U.S. Trade Representative (USTR)

Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)

Client expense: $510,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $530,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 2484 Seniors Access to Critical Medications Act H.R. 2853 Combating Organized Retail Crime Act H.R. 3164 Ensuring Community Access to Pharmacist Services Act H.R. 4317 PBM Reform Act S. 526 Pharmacy Benefit Manager (PBM) Transparency Act S. 527 Prescription Pricing for the People Act S. 882 Patients Before Middlemen (PBM) Act S. 927 Protecting Pharmacies in Medicaid Act S. 1404 Combating Organized Retail Crime Act S. 2426 Equitable Community Access to Pharmacist Services Act S. 3345 PBM Price Transparency and Accountability Act H.R. 6609 Pharmacists Fight Back in Medicare and Medicaid Act H.R. 6575 CommonGround for Affordable Health Care Act H.R. 6501 Bipartisan Health Insurance Affordability Act H.R. 5256 340B ACCESS Act H.R. 4581 340B PATIENTS Act S. 2372 340B PATIENTS Act H.R. 6400 Rx ACCESS Act S. 4106 Rx ACCESS Act S. 3788 CLEAR LABELS Act S. 4509 Patients Before Monopolies Act H.R. 8779 Patients Before Monopolies Act S. 3822 Break Up Big Medicine Act H.R. 8800 National Defense Authorization Act S. 4784 National Defense Authorization Act

Client expense: $290,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.3822 - Break Up Big Medicine Act, all provisions S.526 - Pharmacy Benefit Manager Transparency Act of 2025, all provisions S.527 - Prescription Pricing for the People Act of 2025, all provisions Draft: Removal of oral phenylephrine from the Food and Drug Administrations over-the-counter monograph and subject such products to the drug approval process under section 505 of the Federal Food, Drug, and Cosmetic Act, and for other purposes Drug Shortages

Client expense: $5,130,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.3822 - Break Up Big Medicine Act, all provisions S.526 - Pharmacy Benefit Manager Transparency Act of 2025, all provisions S.527 - Prescription Pricing for the People Act of 2025, all provisions Draft: Removal of oral phenylephrine from the Food and Drug Administrations over-the-counter monograph and subject such products to the drug approval process under section 505 of the Federal Food, Drug, and Cosmetic Act, and for other purposes Drug Shortages

Client expense: $513,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; S. 3822, Break Up Big Medicine Act, MFN Drug pricing issues, including CMMI models; HHS 340B pilot program, Affordability and consolidation issues, 2026 Medicare Physician Fee Schedule issues.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

SUPPORT- Medicare for All (S. 1506 / H.R. 3069) Attended meeting on Break Up Big Medicine Act (S. 3822), introduced by Senator Warren and Hawley. Meetings were with Senator Ron Wyden Meeting with Congressional Progressive Caucus staff on Medicare for All Act (S. 1506 / H.R. 3069) Support S.1709/HR3415, Nursing Staffing Standards for Hospital Patient Safety and Quality Care Act Meeting with Senator Fetterman staff on Medicare for All Act (S. 1506 / H.R. 3069) "Meeting with Representative Alexandria Ocasio-Cortez staff to discuss Medicare for All Act (S. 1506 / H.R. 3069) " Coalition call with Senator Bernie Sander's team to discuss upcoming hearing on April 22 Secretary of HHS Robert F. Kennedy Jr on the FY27 Presidents HHS request Meeting with HELP Committee staff to discuss upcoming April 22 Committee hearing with Secretary of HHS Robert F. Kennedy Jr on the FY27 Presidents HHS request In response to hearing titled Lowering Health Care Costs for All Americans: Examining Policies to Increase Health Care Transparency, urged House Energy and Commerce Committee to markup H.R. 3069, Medicare for All Act. Support Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act SUPPORT- Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act (S. 1709 / H.R. 3415)

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Education related to issues confronting independent physicians, including S. 3822-Break up Big Medicine Act. General issues related to pharmaceutical supply chain.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES